CA5B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.25894908018654E-13 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.72899999989684E-07 |
Normal-vs-Stage2 |
7.201200E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
7.440000E-03 |
Stage1-vs-Stage2 |
5.844600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.381200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.207400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.34707866662166E-12 |
Normal-vs-AfricanAmerican |
1.003370E-01 |
Normal-vs-Asian |
7.965900E-02 |
Caucasian-vs-AfricanAmerican |
1.852390E-02 |
Caucasian-vs-Asian |
1.654280E-02 |
AfricanAmerican-vs-Asian |
9.132400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.98780000000487E-05 |
Normal-vs-Female |
2.1871999766887E-09 |
Male-vs-Female |
1.397660E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.520500E-03 |
Normal-vs-Extreme_Weight |
5.93989999964073E-07 |
Normal-vs-Obese |
1.135950E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.358000E-01 |
Normal_Weight-vs-Obese |
9.087200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.881200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.736600E-01 |
Normal-vs-Age(41-60Yrs) |
1.602890E-04 |
Normal-vs-Age(61-80Yrs) |
3.89340000239713E-08 |
Normal-vs-Age(81-100Yrs) |
4.236800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.816600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.753800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.608200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.692400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.828800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.078800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.880800E-01 |
Normal-vs-Grade 3 |
5.254400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.121400E-01 |
Grade 2-vs-Grade 4 |
4.880800E-01 |
Grade 3-vs-Grade 4 |
5.254400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.55679996566494E-09 |
Normal-vs-N1 |
7.881900E-03 |
N0-vs-N1 |
6.515200E-01 |
|
|